Quest Diagnostics (DGX) reported Q1 adjusted earnings Tuesday of $2.21 per diluted share, up from $2.04 a year earlier.
Analysts polled by FactSet expected $2.15.
Revenue for the quarter ended March 31 was $2.65 billion, up from $2.37 billion a year earlier.
Analysts surveyed by FactSet expected $2.63 billion.
For 2025, the medical diagnostics company reaffirmed its adjusted diluted EPS expectation of $9.55 to $9.80.
Analysts polled by FactSet expect $9.68.
Shares of the company were down more than 3.5% in recent premarket activity.